Cargando…

Albumin-based drug delivery as novel therapeutic approach for rheumatoid arthritis

Detalles Bibliográficos
Autores principales:	Wunder, A, Muller-Ladner, U, Stelzer, E, Neumann, E, Sinn, H, Gay, S, Fiehn, C
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2003
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833800/ http://dx.doi.org/10.1186/ar810

Ejemplares similares

Evidence for synovial fibroblasts spreading rheumatoid arthritis
por: Müller-Ladner, Ulf, et al.
Publicado: (2012)

Mechanisms of resistance against Fas-induced apoptosis in rheumatoid arthritis synovial fibroblasts
por: Pap, T, et al.
Publicado: (2003)

The inhibitor of differentiation-2 promotes synovial fibroblast-dependent osteoclastogenesis in rheumatoid arthritis
por: Kurowska-Stolarska, M, et al.
Publicado: (2005)

Therapeutic targets for rheumatoid arthritis: lessons from animal models
por: Iwakura, Yoichiro, et al.
Publicado: (2012)

Markers in rheumatoid arthritis
por: Breedveld, FC
Publicado: (2004)

Adipocytokines and autoimmunity
por: Frommer, Klaus W, et al.
Publicado: (2011)

IFN-β for the treatment of rheumatoid arthritis?
por: Tak, P, et al.
Publicado: (2003)

Overview of biotherapy in rheumatoid arthritis (RA)
por: Takeuchi, Tsutomu, et al.
Publicado: (2012)

OA17 Rheumatoid meningitis - a rare complication of rheumatoid arthritis
por: Ibrahim, Asma, et al.
Publicado: (2023)

IL-21R mRNA is overexpressed in systemic sclerosis and contributes to the epidermal/dermal cross-talk
por: Distler, O, et al.
Publicado: (2003)

Chemokines in rheumatoid arthritis: novel, potential therapeutic targets of the CCR2 chemokine receptor signaling pathway
por: Matsushima, K, et al.
Publicado: (2003)

Signal transduction inhibitors for the treatment of rheumatoid arthritis
por: Tanaka, Yoshiya, et al.
Publicado: (2012)

IL-17, synoviolin and rheumatoid arthritis chronicity
por: Miossec, Pierre
Publicado: (2012)

Angiogenesis in rheumatoid arthritis: the role of fut 1
por: Koch, Alisa Erika
Publicado: (2012)

Adverse effects of rheumatoid arthritis on bone remodeling
por: Goldring, SR, et al.
Publicado: (2004)

The potential role of adiponectin in driving arthritis
por: Müller-Ladner, U, et al.
Publicado: (2004)

Novel tools for molecular analysis in synovium
por: Mueller-Ladner, U, et al.
Publicado: (2003)

Fifty years' experience in resarch for pathogenesis of rheumatoid arthritis.
por: Zvaifler, NJ
Publicado: (2003)

Skeletal involvement in the pathogenesis and outcomes of rheumatoid arthritis and osteoarthritis
por: Pelletier, Jean-Pierre
Publicado: (2012)

Hyper-ERAD: a novel pathomechanism for rheumatoid arthritis
por: Nakajima, T, et al.
Publicado: (2004)

Angiogenesis and arthritis: a potential therapeutic target?
por: Grosjean, J, et al.
Publicado: (2004)

SKG mice, a new genetic model of rheumatoid arthritis
por: Sakaguchi, S, et al.
Publicado: (2003)

Cell biology of synovial inflammation and secondary osteoporosis in rheumatoid arthritis
por: Tanaka, Y, et al.
Publicado: (2003)

nab-Paclitaxel (Abraxane(®)): an albumin-bound cytotoxic exploiting natural delivery mechanisms into tumors
por: Iglesias, J
Publicado: (2009)

Molecular signatures of rheumatoid arthritis characterized by transcriptome and proteome analysis
por: Glocker, MO, et al.
Publicado: (2005)

Genome-wide single nucleotide polymorphism analyses on rheumatoid arthritis
por: Yamamoto, K, et al.
Publicado: (2004)

Development of the Salford Rheumatoid Arthritis Foot Evaluation Instrument (SAFE)
por: Walmsley, Steven, et al.
Publicado: (2013)

The role of Bob1 in rheumatoid arthritis: potential implications for autoimmunity
por: Yeremenko, Nataliya, et al.
Publicado: (2012)

Podiatrists’ perspectives of the provision of foot health education for people with Rheumatoid Arthritis
por: Graham, Andrea, et al.
Publicado: (2010)

Prevalence of MTP joint involvement in the painful forefoot of patients with Rheumatoid Arthritis
por: Siddle, Heidi, et al.
Publicado: (2010)

Rheumatoid arthritis: a heterogeneous disease evaluated by DNA-microarray technology
por: Kasperkovitz, PV, et al.
Publicado: (2004)

Premise: traditional disease-modifying antirheumatic drugs are less effective and safe than targeted therapy with biologic response modifiers in rheumatoid arthritis
por: Fleischmann, R
Publicado: (2003)

Choosing shoes: a preliminary study into the challenges facing clinicians in assessing footwear for rheumatoid arthritis patients
por: Silvester, Renee N, et al.
Publicado: (2011)

Candidate targets for antibody therapy of rheumatoid arthritis: CD64 and IL-15
por: van de Winkel, J
Publicado: (2003)

Occurrence and risk factors for falls in adults with rheumatoid arthritis: a systematic review
por: Brenton-Rule, Angela, et al.
Publicado: (2013)

Clinical practice guidelines for the foot and ankle in rheumatoid arthritis: a critical appraisal
por: Hennessy, Kym, et al.
Publicado: (2013)

Podiatry care in rheumatoid arthritis: differences between current and ideal service provision
por: Hennessy, Kym, et al.
Publicado: (2013)

Foot involvement in early rheumatoid arthritis: a prospective study of ultrasound features
por: Newcombe, Lisa, et al.
Publicado: (2013)

OA21 Are novel anti-IL5 biologics triggering rheumatoid arthritis?
por: Dean, Nathan, et al.
Publicado: (2023)

Fibroblast biology: Role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis
por: Pap, Thomas, et al.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_j36qiqvjeiopc5o9uc7bf8qprh